China Animal Husbandry Industry Co., Ltd. Class A

China Animal Husbandry Industry Co., Ltd. Class A

SSSE:600195
6.11
CNY
-0.03
(-0.49%)
0.01EPS
1,623.72P/E
6.87BMarket Cap
Apr 09Next Earn
China Animal Husbandry Industry Co., Ltd. Class A
SSE:600195
(Shanghai Stock Exchange)

Recent

price

6.11

P/E

ratio

1,623.72

div

yld

1.26%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.92
3.31
3.39
3.91
4
4.19
3.93
4.03
4.39
4.07
4.93
5.22
5.78
5.29
5.89
6.08
6.21
Revenue per Share
0.34
0.48
0.26
0.25
0.29
0.27
0.33
0.4
0.41
0.25
0.41
0.51
0.54
0.39
0.07
0.17
- -
Basic EPS, GAAP
0.48
0.34
-0.24
-0.01
-0.11
0.19
0.43
-0.04
-0.03
-0.43
0.13
-0.09
-0.67
-0.26
-0.04
0.9
- -
Free Cash Flow per Basic Share
0.08
0.16
0.17
0.1
0.08
0.1
0.09
0.15
0.19
0.18
0.09
0.13
0.16
0.21
0.16
0.05
0.08
Dividend per Share
1.66
2.03
2.11
2.58
2.83
3.01
3.31
3.64
3.96
4.15
4.41
4.84
5.19
5.41
5.39
5.55
5.55
Book Value per Share
1.46
1.84
1.89
2.35
2.48
2.59
2.82
3.08
3.33
3.37
3.67
4.1
4.47
4.57
4.6
4.88
4.46
Tangible Book Value per Share
911
916
916
932
1,010
1,010
1,010
1,010
1,010
1,016
1,014
1,016
1,018
1,021
1,021
1,021
1,021
Basic Weighted Avg Shares
2,661
3,029
3,109
3,640
4,035
4,234
3,974
4,070
4,434
4,136
4,999
5,302
5,892
5,406
6,017
6,205
6,336
Sales/Revenue/Turnover
13.39
11.34
7.81
7.26
5.42
7.07
7.12
6.7
8.02
4.74
7.29
9.76
6.83
4.43
0.89
1.08
2.58
Operating Margin (%)
80
81
89
89
139
162
177
180
168
183
188
262
265
297
321
346
- -
Depreciation Expense
310
440
235
236
290
276
334
400
416
249
420
514
550
403
71
171
4
Net Income, GAAP
14.89
15.65
16.4
16.89
14.64
16.34
15.65
13.95
13.63
16.08
11.71
12.24
12.13
14.63
37.45
19.11
84.38
Effective Tax Rate (%)
11.65
14.52
7.54
6.48
7.19
6.51
8.42
9.83
9.37
6.03
8.41
9.69
9.34
7.46
1.18
2.76
0.07
Profit Margin (%)
541
796
903
1,281
1,002
899
2,198
2,385
1,421
1,307
1,551
1,489
1,858
2,382
1,890
1,852
2,016
Working Capital
- -
- -
- -
- -
- -
- -
1,191
1,193
- -
40
85
84
35
901
666
301
1,328
LT Debt
1,733
2,072
2,182
2,858
3,176
3,356
3,676
3,954
4,485
4,773
5,369
5,874
6,342
6,541
6,499
6,560
7,001
Total Equity
16.91
21.58
11.4
9.72
9.16
8.37
8.46
8.4
8.14
5.04
11.56
10.14
8.63
4.74
0.76
2.82
0.28
Return on Invested Capital (%)
14.84
20.99
10.84
9.09
10.09
8.43
8.15
8.13
7.63
4.3
7.19
7.71
8.81
6.6
1.36
2.51
-0.01
Return on Capital (%)
22.26
26.03
12.36
10.38
10.62
9.36
10.48
11.38
10.83
6.09
9.69
10.94
10.78
7.45
1.29
3.07
0.08
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
881
844
709
LT Borrowings
349
267
1,324
LT Finance Leases
5
2
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,021
1,021
1,021
Market Capitalization
7,567
6,025
6,872

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,726
4,555
4,597
Cash, Cash Equivalents & STI
1,897
1,851
1,650
Accounts Receivable, Net
999
1,082
1,130
Inventories
1,098
1,095
1,277
Total Current Liabilities
2,733
2,568
2,582
Payables & Accruals
- -
- -
- -
ST Debt
881
844
709
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.02%
4.16%
0.93%
Free Cash Flow
-97.38%
-427.26%
-2,435.6%
Net Income, GAAP
13.52%
12.36%
141.68%
Sales/Revenue/Turnover
4.27%
4.67%
3.11%
Total Cash Common Dividend
3.33%
1.69%
-69.61%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,125
1,354
1,699
1,839
6,017
2025
1,259
1,534
- -
1,762
6,205
2026
1,509
1,662
1,403
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
-0.01
0.02
-0.01
0.07
2025
0.06
0.02
- -
-0.05
0.17
2026
0.02
0.03
0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.13
0.01
0.16
2025
0.01
- -
- -
0.01
0.05
2026
- -
0.01
0.06
- -
- -
Business
China Animal Husbandry Industry Co., Ltd. (600195.SS) engages in the research, development, production, and distribution of animal health products and services in China. The company offers a comprehensive portfolio of veterinary pharmaceuticals, including antibiotics, vaccines, and feed additives; biological products such as poultry and livestock vaccines; nutritional supplements and premixes for animal feed; and diagnostic reagents and testing services for disease prevention and control. It operates primarily in the animal husbandry sector, serving livestock farmers, feed mills, and veterinary clinics across mainland China, with headquarters in Beijing and founded in 1998. In recent developments, the company expanded its product offerings through strategic partnerships with international biotech firms for advanced vaccine technologies in 2024; completed a funding round to support new manufacturing facilities in 2025; and launched innovative recombinant protein-based vaccines for porcine diseases amid rising demand in the swine industry.